Investor purchases 149,253,731 common shares at $1.005 each
By Toni Weeks
San Luis Obispo, Calif., Nov. 21 – Lexicon Pharmaceuticals, Inc. negotiated a $150 million private placement of stock on Thursday with Artal International SCA, according to an 8-K filed with the Securities and Exchange Commission.
The company will sell 149,253,731 common shares at $1.005 each. The price is identical to the closing share price on Nov. 19. It is also the same as that from the company’s concurrent public offering of stock led by J.P. Morgan Securities LLC and Goldman Sachs & Co., which will raise $47 million.
Based in the Woodlands, Texas, Lexicon develops treatments for human diseases.
| Issuer: | Lexicon Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $150 million
|
| Shares: | 149,253,731
|
| Price: | $1.005
|
| Warrants: | No
|
| Investor: | Artal International SCA
|
| Pricing date: | Nov. 20
|
| Stock symbol: | Nasdaq: LXRX
|
| Stock price: | $1.005 at close Nov. 19
|
| Market capitalization: | $489.09 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
